Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with …
$61.10+0.93%
报价 2026-11-13
市值
$1.77B
EV
$1.9B
PE (TTM)
14.8x
预期 PE (FY2026)
47.0x
52 周区间距高点 -57.6%
$40.05$143.99
筛选结果
pipeline · 2026-11-13Filter✗ 高增长✗ Cheap✗ GARP
does not hit growth, cheap, or GARP pool
爆发潜力
2026-11-13未命中✗ 收入线✗ EPS 线
| 财年 | 收入倍数 | EPS | PE |
|---|---|---|---|
| FY+22027-12 | 1.0x | 2.03 → 1.52（0.8x） | 40.1 |
| FY+32028-12 | 1.1x | 2.03 → 2.05（1.0x） | 29.9 |
毛利率 86% · TTM 收入 $881M · 基数 EPS 2.03（调整后）
研究结论
还没有研究记录。先生成 L2 基本面报告（约 1–3 分钟），结论会显示在这里。
去生成基本面报告 →历史股价
加载中…
事件
0 条 · 随区间与图例筛选该区间内无事件。
同行对比
FMP 同行列表 · 2026-05-16| 公司 | 市值 | 今日 | 预期营收增速 | 毛利率 | PE | EV/EBITDA | P/FCF | 池 |
|---|---|---|---|---|---|---|---|---|
| INSPInspire Medical Systems, Inc. | $1.77B | +0.9% | -5.8% | 85.5% | 14.8x | 22.8x | 17.1x | |
| ITGRInteger Holdings Corporation | $4.31B | +0.2% | -1.7% | 24.3% | 34.2x | 18.0x | 38.2x | |
| RCUSArcus Biosciences, Inc. | $2.51B | -1.9% | -70.6% | 97% | – | – | – | |
| ARDTArdent Health Partners, LLC | $2.51B | +0.7% | +2.0% | 15.9% | 17.5x | 8.4x | 9.1x | |
| ADUSAddus HomeCare Corporation | $2.29B | -0.6% | +7.1% | 32.2% | 20.3x | 12.9x | 14.1x | |
| BKDBrookdale Senior Living Inc. | $2.19B | +2.3% | -9.5% | 28.7% | – | 18.0x | 151.5x | |
| LMATLeMaitre Vascular, Inc. | $1.79B | +0.8% | +11.3% | 71.7% | 42.4x | 28.8x | 26.7x | |
| PRCTPROCEPT BioRobotics Corporation | $1.37B | +1.2% | +21.1% | 66.3% | – | – | – | |
| AORTArtivion, Inc. | $931.9M | -1.5% | +10.8% | 61.4% | – | 31.8x | – | |
| 同行中位数 | – | – | +4.6% | 46.8% | 27.2x | 18.0x | 26.7x |
研究全文
L2 基本面 memo
尚无基本面 memo
点击「生成基本面报告」——基于最新 filings、电话会纪要与分析师共识生成 L2 memo。
财务报表
| Metric | 2026-06-30 Q2 2026 | 2026-03-31 Q1 2026 | 2025-12-31 Q4 2025 | 2025-09-30 Q3 2025 | 2025-06-30 Q2 2025 | 2025-03-31 Q1 2025 | 2024-12-31 Q4 2024 | 2024-09-30 Q3 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $200.6M | $204.6M | $269.1M | $224.5M | $217.1M | $201.3M | $239.7M | $203.2M |
| Gross Margin | 85.5% | 86.5% | 86.6% | 85.8% | 84% | 84.7% | 85% | 84.1% |
| Operating Margin | -0.3% | -0.5% | 17.1% | 4.3% | -1.5% | -0.7% | 13.3% | 7% |
| Net Income | $314,000 | $-11.3M | $136.1M | $9.9M | $-3.6M | $3M | $35.2M | $18.5M |
| Diluted EPS | 0.01 | -0.39 | 4.66 | 0.34 | -0.12 | 0.1 | 1.15 | 0.6 |
| Operating Cash Flow | $23.2M | $12.8M | $52.5M | $68.5M | $2.7M | $-6.7M | $69.2M | $52.3M |